Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Idioma
Tipo del documento
Publication year range
1.
Tsitologiia ; 48(2): 83-94, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-16737175

RESUMEN

Much effort has been made in searching for multipotent cell types with high therapeutic potentials for repair of damaged tissue. Through enzymatic digestion of fat tissue, it is possible to obtain a large number of stromal cells. Isolated cells show a high proliferate capacity in culture. All this makes adipose stromal cells (ASC) promising candidates for their use in cell therapy. This review is focused on analyzing the surface antigen profile of isolated population of ASC, expression of angiogenic factors by these cells, as well as on their differentiation potential. A high percentage of ASC population initially express the progenitor cell marker CD34, but during culturing, cells exhibit a mesenchymal cell phenotype and express CD29, CD105, CD106, CD166. Culturing ASC in specific differentiation media induces expression of early markers of differentiated mesenchymal cells, such as adipocytes, chondrocytes and osteoblasts, as well as myoblasts, cardiomyocytes and neural cells. It has been also shown that ASC have a strong pro-angiogenic potential, they are able to secret growth factors, such as VEGF, HGF, bFGF and others, which stimulate survival and proliferation of endothelial cells. In addition, systemic or local delivery of ASC to mice with hindlimb ischemia stimulates recovery of injured tissue and blood flow. Potential clinical uses of ASCs are discussed in the review.


Asunto(s)
Tejido Adiposo/citología , Células del Estroma/citología , Adipocitos/citología , Tejido Adiposo/metabolismo , Tejido Adiposo/fisiología , Animales , Antígenos CD/metabolismo , Antígenos CD34/metabolismo , Moléculas de Adhesión Celular Neuronal/metabolismo , Diferenciación Celular , Proliferación Celular , Trasplante de Células , Células Cultivadas , Condrocitos/citología , Medios de Cultivo , Endoglina , Proteínas Fetales/metabolismo , Pie/irrigación sanguínea , Pie/patología , Sustancias de Crecimiento/metabolismo , Humanos , Integrina beta1/metabolismo , Isquemia/patología , Isquemia/terapia , Ratones , Mioblastos/citología , Mioblastos Cardíacos/citología , Neuronas/citología , Osteoblastos/citología , Receptores de Superficie Celular/metabolismo , Células del Estroma/metabolismo , Células del Estroma/fisiología , Molécula 1 de Adhesión Celular Vascular/metabolismo
2.
Kardiologiia ; 46(6): 53-63, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-16883224

RESUMEN

Results of studies of properties of adipose tissue stromal cells are summarized in this review. It contains data on separation and cultivation of these cells as well as description of their antigenic characteristics, ability to differentiate into cells of mesenchymal and nonmesenchymal origin, angiogenic potential, and potential for transfection and transfer of therapeutic genes. Analysis of perspectives of clinical use of adipose tissue stromal cells in therapy of cardiovascular and other diseases is also presented.


Asunto(s)
Tejido Adiposo/citología , Isquemia/cirugía , Células Madre Multipotentes/trasplante , Neovascularización Fisiológica , Trasplante de Células Madre/métodos , Animales , Humanos , Isquemia/patología , Células del Estroma/citología
3.
Ross Fiziol Zh Im I M Sechenova ; 90(5): 547-68, 2004 May.
Artículo en Ruso | MEDLINE | ID: mdl-15341081

RESUMEN

The review summarizes data obtained by the authors and other laboratories concerning the role of urokinase plasminogen activator in vessel remodeling and angiogenesis. The data have shown that urokinase is involved in unfavorable vascular remodeling during the development of restenosis, atherosclerosis and also in the regulation of angiogenesis. Urokinase is a promising target for therapeutic interventions aimed at restenosis prevention. Urokinase gene therapy may be a perspective strategy for the treatment of tissue ischemia.


Asunto(s)
Arteriosclerosis/terapia , Terapia Genética , Isquemia/terapia , Activadores Plasminogénicos/administración & dosificación , Activador de Plasminógeno de Tipo Uroquinasa/administración & dosificación , Animales , Arteriosclerosis/patología , Humanos , Isquemia/patología , Neovascularización Fisiológica/efectos de los fármacos , Neovascularización Fisiológica/genética , Activadores Plasminogénicos/genética , Ratas , Activador de Plasminógeno de Tipo Uroquinasa/genética
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda